SUBSCRIBE
SUBSCRIBE

IntelliPharmaCeutics Provides Update on Activities Related to 30mg Generic Version of Focalin XR(R)

March 30, 2011 | 
1 min read

TORONTO, March 29, 2011 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), today announced the following with regard to its generic drug commercialization activities.